BASG/AGES PharmMed warn against the use of the weight loss tea "Paiyouji". Analyses in the Austrian Drug Control Laboratory (OMCL of AGES PharmMed) showed that this product contains a possibly carcinogenic indicator substance as well as a chemical active pharmaceutical ingredient that is subject to prescription. "Paiyouji" poses a great health risk…

In 2006, after the completion of the major review of pharmaceutical legislation, the Commission published ideas to further improve the legislation of proprietary medicinal product variation applications. The basic idea was: Simplification of administrative processes Harmonization of all procedures (national, MRP and CP) Implementation of the ICH…

Re-emergence of a case in Bucharest.

Occurrence of a confirmed case in the province of Bologna/Ferrara.

The following quality defect has been identified in the drug product Ionsys (Fentanyl) 40 microgram per dose iontophoretic transdermal system: A defect in the IONSYS systems may potentially cause the system to self-activate. See related files.

Exchange of unbuffered and weakly buffered infusion solutions. See associated files.

Information to ensure the safety of Neupro. See related files.

Communication from the Federal Office for Safety in Health Care on Gardasil. You related file.

Information on the suspension of marketing of parenterally administrable drug products containing aprotinin. See related files.

Information on market withdrawal of Clobutinol-containing drugs (Silomat®) up to and including patient level. See related files.